Articles dans des revues avec comité de lecture (6)
  1. 1. Gilglioni, E. H., Li, A., St-Pierre-Wijckmans, W., Shen, T.-K., Perez Chavez, I., Hovhannisyan, G., Lisjak, M., Negueruela Escudero, J., Vandenbempt, V., Bauzá-Martinez, J., Herranz, J. M., Ezeriņa, D., Demine, S., Feng, Z., Vignane, T., Otero Sanchez, L., Lambertucci, F., Prašnická, A., Devière, J., Hay, D. C., Encinar, J. A., Singh, S. P., Messens, J., Filipovic, M. R., Sharpe, H. J., Trepo, E., Wu, W., & Gurzov, E. N. (2024). PTPRK regulates glycolysis and de novo lipogenesis to promote hepatocyte metabolic reprogramming in obesity. Nature communications, 15(1), 9522. doi:10.1038/s41467-024-53733-0
  2. 2. Negueruela Escudero, J., Vandenbempt, V., Talamantes, S., Ribeiro-Costa, F., Nunes, M., Marques Dias, A., Bansal, M., & Gurzov, E. N. (2024). Protocol for CRISPR-Cas12a genome editing of protein tyrosine phosphatases in human pluripotent stem cells and functional β-like cell generation. STAR Protocols, 5(3), 103297. doi:10.1016/j.xpro.2024.103297
  3. 3. Vandenbempt, V., Eski, S. E., Brahma, M. K., Li, A., Negueruela Escudero, J., Bruggeman, Y., Demine, S., Xiao, P., Cardozo, A. K., Baeyens, N., Martelotto, L., Singh, S. P., Mariño, E., Gysemans, C., & Gurzov, E. N. (2023). HAMSAB diet ameliorates dysfunctional signaling in pancreatic islets in autoimmune diabetes. iScience, 27(1), 108694. doi:10.1016/j.isci.2023.108694
  4. 4. Brahma, M. K., Xiao, P., Popa, M., Negueruela Escudero, J., Vandenbempt, V., Demine, S., Cardozo, A. K., & Gurzov, E. N. (2022). Nova1 or Bim Deficiency in Pancreatic β-Cells Does Not Alter Multiple Low-Dose Streptozotocin-Induced Diabetes and Diet-Induced Obesity in Mice. Nutrients, 14(18). doi:10.3390/nu14183866
  5. 5. Elvira Jimenez, B., Vandenbempt, V., Bauzá-Martinez, J., Crutzen, R., Negueruela, J., Ibrahim, H., Winder, M. M., Brahma, M. K., Vekeriotaite, B., Martens, P.-J., Singh, S. P., Rossello, F., Lybaert, P., Otonkoski, T., Gysemans, C., Wu, W., & Gurzov, E. N. (2022). PTPN2 Regulates the Interferon Signaling and Endoplasmic Reticulum Stress Response in Pancreatic Beta-Cells in Autoimmune Diabetes. Diabetes (New York, N.Y.). doi:10.2337/db21-0443
  6. 6. Schaschkow, A., Pang, L., Vandenbempt, V., Elvira Jimenez, B., Litwak, S. A., Vekeriotaite, B., Maillard, E., Vermeersch, M., Moura De Paula, F., Pinget, M., Perez-Morga, D., Gough, D. J., & Gurzov, E. N. (2021). STAT3 Regulates Mitochondrial Gene Expression in Pancreatic Beta-Cells and Its Deficiency Induces Glucose Intolerance in Obesity. Diabetes (New York, N.Y.), 70(9), 2026-2041. doi:10.2337/db20-1222
    7.   Communications publiées lors de congrès ou colloques nationaux et internationaux (4)
  7. 1. Vandenbempt, V., Eski, S. E., Brahma, M. K., Li, A., Demine, S., Xiao, P., Cardozo, A. K., Singh, S. P., Mariño, E., Gysemans, C., & Gurzov, E. N. (2022). Single-cell sequencing reveals preserved pancreatic islet cell identity by administration of metabolite-based diet in autoimmune diabetes. Diabetologia, Vol. 65 , 211. doi:10.1007/s00125-022-05755-w
  8. 2. Brahma, M. K., Xiao, P., Popa, M., Vandenbempt, V., Negueruela Escudero, J., Cardozo, A. K., & Gurzov, E. N. (2021). The Nova1-Bim axis in pancreatic beta-cells does not impact glucose homeostasis in obesity and multiple low-dose streptozotocin-induced diabetes. Diabetologia,(64 (Suppl 1):S1–S380). doi:10.1007/s00125-021-05519-y
  9. 3. Vandenbempt, V., Elvira Jimenez, B., Bauzá-Martinez, J., Negueruela Escudero, J., Ibrahim, H., Winder, M. M., Vekeriotaite, B., Singh, S. P., Rossello, F., Lybaert, P., Otonkoski, T., Gysemans, C., Wu, W., & Gurzov, E. N. (2021). PTPN2 regulates the interferon signalling in pancreatic beta-cells and its expression correlates with therapy outcome in autoimmune diabetes.
  10. 4. Elvira Jimenez, B., Vandenbempt, V., & Gurzov, E. N. (2020). Ptpn2 is a pro-inflammatory cytokine regulator and novel player in the endoplasmic reticulum stress response in beta cells. Diabetologia